Lingshu Wang

National Institutes of Health

Papers

1

Total Citations

8

H-Index

1

About

Lingshu Wang is a leading virologist whose research focuses on the isolation and characterization of broadly neutralizing antibodies against emerging coronaviruses. In a pivotal 2021 study, Wang and colleagues identified cross-neutralizing antibodies from COVID-19 convalescent subjects, demonstrating that these antibodies could neutralize not only SARS-CoV-2 but also other sarbecoviruses, including SARS-CoV-1. This work, which has garnered 8 citations, provided critical insights into the structural basis of antibody-mediated protection and opened new avenues for designing universal coronavirus vaccines and therapeutics. By mapping the epitopes targeted by these potent antibodies, Wang’s research has advanced our understanding of immune evasion and viral evolution. Their contributions are instrumental in the fight against current and future coronavirus threats, highlighting the potential for broadly protective interventions. Wang’s findings continue to inform vaccine design and monoclonal antibody development, underscoring their impact on pandemic preparedness and global health security.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects
8 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 28
🏛 Institutions: National Institutes of Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago